Erratum: Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: A randomized, placebo-controlled study (Journal of Investigative Dermatology (2015) 135 (67-75)) DOI: 10.1038/jid.2014.306)

Sarbjit S. Saini, Carsten Bindslev-Jensen, Marcus Maurer, Jean Jacques Grob, Emel Bülbül Baskan, Mary S. Bradley, Janice Canvin, Abdelkader Rahmaoui, Panayiotis Georgiou, Oral Alpan, Sheldon Spector, Karin Rosén

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)925
Number of pages1
JournalJournal of Investigative Dermatology
Volume135
Issue number3
DOIs
StatePublished - Mar 12 2015

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this